IL17A and pulmonary fibrosis: It has been shown that IL-17A, the main cytokine of type 17 immunity, is able to induce EMT through the production of TGF-β, direct stimulation of fibroblasts and fibrocytes, and autophagy inhibition that otherwise would protect against lung fibrosis [26].